Dyslipidemia:
Indications for Intervention – Hypercholesterolemia
(National Cholesterol Education Program)




Initiate dietary intervention Consider drug
therapy
LDL-C goal
Without CHD and less than 2 risk factors* >160 mg/dL
>190 mg/dL
<160 mg/dL
Without CHD and with 2 or more risk factors >130 mg/dL
>160 mg/dL
<130 mg/dL
With CHD >100 mg/dL
>130 mg/dL
<100 mg/dL
 

* Risk factors include age (men > 45 years, women > 55 years or premature menopause without estrogen replacement therapy), family history of CHD (first-degree male relative with CHD before 55 years of age or first-degree female relative before 65 years of age), current cigarette smoking, hypertension, low HDL cholesterol (< 35 mg/dL), diabetes mellitus. In the presence of high HDL cholesterol (> 60 mg/dL), subtract one risk factor.
1. NCEP. Circulation.1994;89:1329-445.

• The National Cholesterol Education Program (NCEP) guidelines1 offer clinicians a good reference point for considering therapy in patients with HIV infection and dyslipidemia.

• The guidelines focus on LDL cholesterol. Estimates of LDL in patients with triglycerides higher than 400 mg/dL, however, may be unreliable. In such patients, a total cholesterol level greater than 240 mg/dL or an HDL cholesterol level less than 35 mg/dL requires dietary intervention initially.

• Risk factors include age 45 and higher for men and age 55 or higher in women or premature menopause without estrogen replacement therapy. A family history of heart disease in a first-degree male relative before 55 years of age or a first-degree female relative before 65 years of age are also risk factors. Other risk factors are smoking, hypertension, an HDL below 35 mg/dL, and diabetes. If a patient has a high HDL above 60 mg/dL, one risk factor can be subtracted.

Reference:

1. National Cholesterol Education Program (NCEP). Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). Circulation. 1994;89:1329-445.




 

HIV AND AIDS
| HEPATITIS B | HEPATITIS C | HIV / HBV CO-INFECTION | HIV / HCV CO-INFECTION | HEALTH AND TECHNOLOGY | TESTS | INTERNET CONFERENCE REPORTS | TELECONFERENCES | LINKS | ABOUT US | CONTACT US